If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() Journal of Paediatrics and Child HealthVolume 43 Issue 3, Pages 167 - 172 Published Online: 16 Feb 2007 Journal compilation © 2010 Paediatrics and Child Health Division (Royal Australasian College of Physicians)
Abstract | References | Full Text: HTML, PDF (Size: 166K) | Related Articles | Citation Tracking ORIGINAL ARTICLE Nocturnal enuresis: Application of evidence-based medicine in community practice Copyright © 2007 The Authors; Journal compilation © 2007 Paediatrics and Child Health Division (Royal Australasian College of Physicians) KEYWORDS desmopressin • enuresis • evidence-based medicine • follow-up studies • private practice ABSTRACTAim: To report the outcomes and follow-up at 2 years of children with monosymptomatic nocturnal enuresis (MNE) managed in a private paediatric community practice utilising body-worn alarms and supportive programmes. Methods: 522 consecutive children presenting with MNE were assessed and managed with a comprehensive supportive programme and body-worn alarm. Data were recorded prospectively and outcomes assessed at 6 and 24 months. Results: 505 proceeded with management. A total of 79.0% achieved initial dryness within a median of 10 weeks. Of those achieving initial dryness 73.0% had remained dry at 6-month follow-up and 64% had remained dry at 24 months. A total of 99.2% follow-up was achieved. Nineteen per cent of children required more than 16 weeks management with 56% achieving dryness. More girls achieved dryness than boys and in a shorter time. There was no gender difference in relapse rates at 6 and 24 months. No difference in achieving initial success was found with respect to initial severity of wetting, nor age. Relapse rates were unrelated to gender, age, or initial severity. Conclusion: MNE can be successfully managed using body-worn alarms achieving good initial and long-term complete dryness, without the need for expensive pharmacologic intervention. A strong supportive programme can make the management less arduous for child and family. Accepted for publication 20 August 2006. |